The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.

[1]  R. Garfein,et al.  Distributive syringe sharing among young adult injection drug users in five U.S. cities. , 2007, Drug and alcohol dependence.

[2]  R. Garfein,et al.  Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. , 2007, Drug and alcohol dependence.

[3]  R. Garfein,et al.  Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). , 2007, Drug and alcohol dependence.

[4]  S. Strathdee,et al.  HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan , 2007, Emerging infectious diseases.

[5]  V. Rustgi.  The epidemiology of hepatitis C infection in the United States , 2007, Journal of Gastroenterology.

[6]  D. Huo,et al.  Needle Exchange and Injection-Related Risk Behaviors in Chicago: A Longitudinal Study , 2007, Journal of acquired immune deficiency syndromes.

[7]  R. Garfein,et al.  Trends in Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Prevalence, Risk Behaviors, and Preventive Measures among Seattle Injection Drug Users Aged 18–30 Years, 1994–2004 , 2007, Journal of Urban Health.

[8]  C. Day,et al.  Self reported risk behaviour among injecting drug users: Self versus assisted questionnaire completion , 2007, AIDS care.

[9]  N. Wright,et al.  A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users , 2006, Harm Reduction Journal.

[10]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[11]  H. Hagan,et al.  Changes in injection risk behavior associated with participation in the seattle needle-exchange program , 2000, Journal of Urban Health.

[12]  R. Garfein,et al.  Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. , 2005, Drug and alcohol dependence.

[13]  D. Huo,et al.  HIV Risk Practices Among Needle Exchange Users and Nonusers in Chicago , 2004, Journal of acquired immune deficiency syndromes.

[14]  Don C Des Jarlais,et al.  Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. , 2004, Addiction.

[15]  R. Garfein,et al.  The Use of Needle Exchange by Young Injection Drug Users , 2003, Journal of acquired immune deficiency syndromes.

[16]  M. Busch,et al.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.

[17]  D. Vlahov,et al.  Does Bleach Disinfection of Syringes Protect Against Hepatitis C Infection Among Young Adult Injection Drug Users? , 2002, Epidemiology.

[18]  D. Vlahov,et al.  Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. , 2002, AIDS education and prevention : official publication of the International Society for AIDS Education.

[19]  R. Garfein,et al.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.

[20]  R. Brookmeyer,et al.  Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. , 2002, American journal of epidemiology.

[21]  A. Estrada.  Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. , 2002, Public health reports.

[22]  D. Vlahov,et al.  Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. , 2001, Journal of substance abuse.

[23]  D. Gibson,et al.  Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. , 2001, AIDS.

[24]  A. Moss,et al.  Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco , 2001, Hepatology.

[25]  D. Vlahov,et al.  Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. , 2001, American journal of public health.

[26]  J. Duchin,et al.  Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.

[27]  D. Vlahov,et al.  Prevention of HIV Infection in Street‐Recruited Injection Drug Users , 2000, Journal of acquired immune deficiency syndromes.

[28]  H. Hagan,et al.  Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area , 2000, Journal of urban health : bulletin of the New York Academy of Medicine.

[29]  B. Edlin,et al.  The effect of syringe exchange use on high-risk injection drug users: a cohort study , 2000, AIDS.

[30]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[31]  N. Weiss,et al.  Reply to “Invited Commentary: Needle Exchange—No Help for Hepatitis?” by Moss and Hahn , 1999 .

[32]  N. Weiss,et al.  Syringe exchange and risk of infection with hepatitis B and C viruses. , 1999, American journal of epidemiology.

[33]  A. Moss,et al.  Invited commentary: needle exchange--no help for hepatitis? , 1999, American journal of epidemiology.

[34]  D. Vlahov,et al.  Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[35]  R Brookmeyer,et al.  Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[36]  N. Crofts,et al.  Methadone maintenance and hepatitis C virus infection among injecting drug users. , 1997, Addiction.

[37]  J. Kaldor,et al.  Effectiveness of needle-exchange programmes for prevention of HIV infection , 1997, The Lancet.

[38]  K. Vranizan,et al.  Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[39]  A. Plant,et al.  Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus , 1977, Australian and New Zealand journal of public health.

[40]  G. Rezza,et al.  Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. , 1996, Scandinavian journal of infectious diseases.

[41]  M. Alter,et al.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. , 1995, American journal of public health.

[42]  D. Vlahov,et al.  Correlates of Hepatitis C Virus Infections among Injection Drug Users , 1995, Medicine.

[43]  J. Watters,et al.  Syringe and needle exchange as HIV/AIDS prevention for injection drug users. , 1994, JAMA.

[44]  A. Lazzarin,et al.  Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study. , 1992, American journal of epidemiology.

[45]  J. Goudsmit,et al.  Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. , 1990, The Journal of infectious diseases.

[46]  J. Parry,et al.  Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year. , 1989, AIDS.